The mandate of the CVMA Expert Panel on rbST, as provided by Health Canada, was to:
Review the scientific data used by the Bureau of Veterinary Drugs to determine that Nutrilac (rbST) when used in accordance with its label directions will increase milk production without resulting in serious health problems which cannot be adequately controlled by current cattle management practices.
Make observations and recommendations regarding the adequacy of the scientific data submitted by the manufacturer of Nutrilac (rbST) or existing elsewhere to make sound scientific assessments regarding the product efficacy and animal health risks associated with the use of Nutrilac (rbST) in Canadian dairy cattle.
Media Inquiries
Margot Geduld
(613) 957-1588
January 1999
We submit the following report to Health Canada to assist them in their evaluation of Monsanto's submission requesting the licencing of Nutrilac (rbST).